Antisense Oligonucleotides for Early Drug Discovery
Several oligonucleotide-based drugs have been approved by regulatory agencies (e.g. FDA and EMEA) during the past two decades. Antisense and RNAi therapeutics are currently among the hottest topics in the world of research and development.